BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23965467)

  • 1. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.
    Ducrocq G; Bhatt DL; Labreuche J; Corbalan R; Porath A; Gao R; Panchenko E; Liau CS; Ikeda Y; Goto S; Amarenco P; Steg PG
    Eur J Prev Cardiol; 2014 Dec; 21(12):1509-16. PubMed ID: 23965467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cacoub PP; Abola MT; Baumgartner I; Bhatt DL; Creager MA; Liau CS; Goto S; Röther J; Steg PG; Hirsch AT;
    Atherosclerosis; 2009 Jun; 204(2):e86-92. PubMed ID: 19054514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry.
    Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox K; Hu D; Shalnova S; Steg PG;
    Eur J Prev Cardiol; 2015 Aug; 22(8):1056-65. PubMed ID: 25147344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease.
    Alvarez LR; Balibrea JM; Suriñach JM; Coll R; Pascual MT; Toril J; López-Jiménez L; Monreal M;
    Eur J Prev Cardiol; 2013 Jun; 20(3):486-95. PubMed ID: 21968571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.
    Uchiyama S; Goto S; Matsumoto M; Nagai R; Origasa H; Yamazaki T; Shigematsu H; Shimada K; Yamada N; Bhatt DL; Steg PG; Ikeda Y;
    J Neurol Sci; 2009 Dec; 287(1-2):45-51. PubMed ID: 19815240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Krempf M; Parhofer KG; Steg PG; Bhatt DL; Ohman EM; Röther J; Goto S; Pasquet B; Wilson PW;
    Am J Cardiol; 2010 Mar; 105(5):667-71. PubMed ID: 20185014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.
    Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M;
    Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year cardiovascular event rates in outpatients with atherothrombosis.
    Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
    JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.
    Ohman EM; Bhatt DL; Steg PG; Goto S; Hirsch AT; Liau CS; Mas JL; Richard AJ; Röther J; Wilson PW;
    Am Heart J; 2006 Apr; 151(4):786.e1-10. PubMed ID: 16569533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
    Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW;
    JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease.
    Ferrari R; Abergel H; Ford I; Fox KM; Greenlaw N; Steg PG; Hu D; Tendera M; Tardif JC;
    Int J Cardiol; 2013 Sep; 167(6):2938-43. PubMed ID: 22985742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cavender MA; Steg PG; Smith SC; Eagle K; Ohman EM; Goto S; Kuder J; Im K; Wilson PW; Bhatt DL;
    Circulation; 2015 Sep; 132(10):923-31. PubMed ID: 26152709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from the REACH Registry in Europe.
    Valentijn TM; Stolker RJ
    Curr Vasc Pharmacol; 2012 Nov; 10(6):725-7. PubMed ID: 23259566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
    Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
    Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.